Call for Applications - BridgeBio
Novel Therapeutics for Genetic Disease
CU Innovations 2020 Annual Report
Invention Disclosure Form goes digital
Fall Innovator Spotlight
Michael Holers, MD Shares Keys To Becoming A Successful Inventor
About CU Innovations
CU Innovations brings together industry partners, entrepreneurs, and investors to help CU Researchers create biomedical technology that improves the quality of life worldwide. With expertise in patents, copyrights, and licensing, CU Innovations translates discovery into impact through transparent, flexible, best practice intellectual property management services.
Located on the University of Colorado Anschutz Medical Campus, CU Innovations provides access to an extensive portfolio of biomedical technologies, clinical validation opportunities, and resources for startup development.
Upcoming Events
Startup Entity Considerations
May 26
4pm - 6pm
Zoom meeting Link will be provided to all registered guests.
News signup
Be first to find out about innovations
.png?sfvrsn=bdc768b9_4 "Facts Banner-01 (1)")
Latest News
Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection
Royal Philips , a global leader in health technology, and BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms. The goal of the award is to accelerate the use of wearable diagnostics for the benefit of military and public health through the early identification and containment of pre-symptomatic COVID-19 cases.
UCHealth deploys BioIntelliSense BioButton™ Vaccine Monitoring Solution to health care workers receiving COVID-19 vaccine
As UCHealth begins administering the Pfizer COVID-19 vaccine to health care workers today at University of Colorado Hospital on the University of Colorado Anschutz Medical Campus, some recipients will be wearing the BioIntelliSense BioButton medical device as a foundational step in developing a scalable post-vaccine monitoring program that could be deployed more broadly in high-risk patient populations.
Four CU Researchers Awarded AIA Funding
A Colorado company with revolutionary technology to create telepresence robotics, designed to expedite adoption of robotic arms in advanced industrial and commercial applications was among 37 Colorado start-ups approved for funding as part of the Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program. A total of $7,657,811 was approved during the first grant cycle of 2021 for Proof-of-Concept and Early Stage Capital and Retention Grants that support Colorado’s advanced industries.
CU Innovations Twitter Feed
CU Innovations
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Mail Stop F411
Aurora, CO 80045
303-724-3720
CMS Login